Structured evidence table for Phytoceramides Skin Hydration Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Phytoceramides Skin Hydration Randomized Trial | This increase has significantly impacted the costs associated with medical treatment and resulted in additional expenses for patients and their families []. | 3 | Ali Sibel (2024) | Emerging Treatments and New Vehicle Formulations for Atopic Dermatitis |
| Phytoceramides Skin Hydration Randomized Trial | 7 8 10 11 Genetic factors contribute to the complexity of the pathophysiology of AD, as certain polymorphisms are associated with changes in skin barrier function and immune responses. | 3 | Ali Sibel (2024) | Emerging Treatments and New Vehicle Formulations for Atopic Dermatitis |
| Phytoceramides Skin Hydration Randomized Trial | For instance, mutations in the filaggrin gene have been linked to a higher risk of developing AD [,]. | 3 | Ali Sibel (2024) | Emerging Treatments and New Vehicle Formulations for Atopic Dermatitis |
| Phytoceramides Skin Hydration Randomized Trial | 1 1 2 3 4 4 1 Atopic dermatitis (AD) is a chronic inflammatory skin disease that mainly affects children, with a prevalence of 10 to 20% []. | 3 | Ali Sibel (2024) | Emerging Treatments and New Vehicle Formulations for Atopic Dermatitis |
| Phytoceramides Skin Hydration Randomized Trial | AD is characterized by elevated levels of skin eosinophils, neutrophils, and mast cells; lymphocyte infiltration; and increased immunoglobulin (Ig) E levels []. | 3 | Pareek Ashutosh (2024) | Unraveling Atopic Dermatitis: Insights into Pathophysiology, Therapeutic Advances, and Future Perspectives |
| Phytoceramides Skin Hydration Randomized Trial | 6 7 8 Children suffering from AD may have a risk of developing asthma, allergic rhinitis, food allergies, and rheumatoid arthritis and a 75% risk of developing the common cold []. | 3 | Pareek Ashutosh (2024) | Unraveling Atopic Dermatitis: Insights into Pathophysiology, Therapeutic Advances, and Future Perspectives |
| Phytoceramides Skin Hydration Randomized Trial | Recent studies have identified cardiovascular and neuropsychiatric disorders as significant comorbidities associated with AD, yet the underlying biological mechanisms linking these conditions to AD are still not fully understood [,]. | 3 | Pareek Ashutosh (2024) | Unraveling Atopic Dermatitis: Insights into Pathophysiology, Therapeutic Advances, and Future Perspectives |
| Phytoceramides Skin Hydration Randomized Trial | 1 2 3 4 Atopic dermatitis (AD), also known as eczema, is a prevalent autoimmune skin disease affecting people worldwide. | 3 | Pareek Ashutosh (2024) | Unraveling Atopic Dermatitis: Insights into Pathophysiology, Therapeutic Advances, and Future Perspectives |
Source documents